A May 2026 Lancet trial found semaglutide reduced heavy drinking days by 41% versus 26% on placebo in patients with alcohol use disorder and obesity, but the drug is not FDA-approved for this use
Methods: 92 LT recipients between 2016 and 2022 were retrospectively reviewed: 46 consecutive hyper-immunized recipients (high-risk group) were matched to 46 non-immunized LT recipients (D/R negative crossmatch and no pDSA, low-risk group)
La administracin transdrmica requiere que los ingredientes atraviesen el estrato crneo, la capa ms externa de la piel, que est especficamente diseada para mantener alejadas las sustancias extraas
Published: Aug 7, 2025 Written by Klarity Editorial Team Published: Aug 7, 2025 Starting a GLP-1 medication like semaglutide (Ozempic or Wegovy) comes with certain expectations, particularly around appetite suppression
Colonoscopies are now recommended starting at age 45 for the general population, and younger for people at higher risk or with a family history